ArticleEuropean journal of medical research2025
Cell deformability enhances adhesion of ATRA-differentiated HL-60 cells to P-selectin.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Acute promyelocytic leukemia (APL) is characterized by immature myeloid cells with unlimited proliferative capacity. All-trans retinoic acid (ATRA) can induce these cells to differentiate, but patients may develop differentiation syndrome (DS), a life-threatening complication linked to abnormal leukocyte recruitment. The mechanisms of DS remain poorly understood, despite insights gained from studies on APL cell lines. In this study, ATRA-differentiated HL-60 cells were perfused into a flow chamber simulating the physiological environment and functionalized with P-selectin to mimic the initial step of leukocyte recruitment. We quantified the adhesive behavior of these cells by measuring the PSGL-1-P-selectin bond lifetime and adhesion rate with and without ATRA treatment. Both parameters increased following ATRA treatment. Flow cytometry revealed that the difference in PSGL-1 expression was minimal. To explore the impact of cell stiffness on adhesion, we fixed cells and performed additional flow chamber experiments. The bond lifetime and adhesion rate of differentiated cells decreased after fixation, suggesting that the altered adhesion behavior was mainly due to changes in cell deformability, with a minimal role played by PSGL-1 expression. These findings highlight the potential role of cell deformability in the enhanced adhesion of ATRA-differentiated cells, offering new insights into the mechanisms of DS and paving the way for improved prevention and treatment strategies for DS in APL patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.